D
Dermoklinika Centrum Medyczne | Lodz, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Zasocitinib
TCP-25
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
This is a Phase 2, double-blind, randomized, vehicle-controlled study designed to evaluate efficacy, safety, and tolerability of topically applied TC...
Enrolling
Epidermolysis Bullosa (EB)
Junctional Epidermolysis Bullosa
Drug: TCP-25 gel
Drug: Vehicle (placebo)
Vitiligo is a long-term autoimmune condition that causes the skin to lose its color. The body's germ-fighting system (immune system) mistakenly attac...
Enrolling
Nonsegmental Vitiligo
Other: Placebo
Drug: Zasocitinib
Trial sponsors
X
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems